Navigation Links
Neose Announces Presentation of Positive Preclinical Data on,GlycoPEGylated Factor VIIa at the XXI Congress of the International,Society on Thrombosis and Haemostasis

$15 billion. For more information, please visit www.neose.com.

Neose "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statement, see the sections of Neose's Annual Report on Form 10-K for the year ended December 31, 2006, entitled "Risk Factors" and "Special Note Regarding Forward-Looking Statements" and discussions of potential risks and uncertainties in Neose's subsequent filings with the SEC.

Contact

Neose Technologies, Inc.
A. Brian Davis
Sr. Vice President and Chief Financial Officer
215-315-9000
or
Barbara Krauter
Manager, Corporate Communications
215-315-9004


'"/>




Page: 1 2

Related medicine technology :

1. Neose Technologies to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:9/4/2008)...atient Identification for Targeted Therapies ...ment HUNTINGTON BEACH, Calif., and AMSTERDAM, N...ld leader in molecular cancer diagnostics,today a...ostic test that,allows physicians to quantitativel...ogen receptor (ER), progesterone receptor (PR) and...
(Date:9/3/2008)...f Rheumatology Research and Education Foundation,s...ances in Detecting, Treating a.../ -- For the first time during its,unprecedented i... the,American College of Rheumatology Research and... acquired from research funded by the Within Our,R...
(Date:9/3/2008)...hat Multaq(R) (dronedarone) decreased the risk of,...or atrial flutter already adequately ....J., Sept. 3 /- The results...A study were presented today at,the clinical trial...ogy,congress 2008, in Munich, Germany. Previous re...
(Date:9/3/2008)...t. 3 /- A sub-analysis of,t...ment with prasugrel,compared with clopidogrel sign...rt attacks (7.4 percent vs. 9.7 percent, p<0.0001)... the time of an artery-opening,procedure known as ...ey,occurred spontaneously during the longer-term m...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6Crdentias National Director of Travel Services Provides an Exclusive Interview on the Growth of Crdentias Travel Nurse Division 2497 1Crdentias National Director of Travel Services Provides an Exclusive Interview on the Growth of Crdentias Travel Nurse Division 2497 2Botched production of insulin molecule may lead to diabetes 625 1Botched production of insulin molecule may lead to diabetes 625 2Botched production of insulin molecule may lead to diabetes 625 3Botched production of insulin molecule may lead to diabetes 625 4New test could help consumers avoid surprise headaches from chocolate wine 622 1New test could help consumers avoid surprise headaches from chocolate wine 622 2New test could help consumers avoid surprise headaches from chocolate wine 622 3Sunnylife Global Retains The Blaine Group For Investor Relations Financial Public Relations 2489 1Sunnylife Global Retains The Blaine Group For Investor Relations Financial Public Relations 2489 2
(Date:9/7/2008)...Upon Students and University Leaders to, Join the ... to Big Tobacco, WASHINGTON, Sept. 8 /PRNewswire-... to aggressive tobacco industry marketing tactics ...ew report released today by the,American Lung Asso...rview of the current status of,tobacco use and pol...
(Date:9/5/2008)...e Latest Developments in Molecular,Testing and Per...Newswire-USNewswire/ -- The practice of,pathology ...d the promise,of personalized medicine will change...other imaging technologies will change the way pat...ts is taking a leadership role in,making sure that...
(Date:9/5/2008)...mane Shows Public Reluctant to Evacuate, Without T...fforts Confirm Survey ...urvey by the American Humane,Association found tha...stance if it meant leaving without their family pe... towards the U.S. coast, residents and,officials s...
(Date:9/5/2008)...to commit to develop a National AIDS,Strategy for ... /PRNewswire-USNewswire/ -- The,Republican Nationa...of the,domestic AIDS epidemic in the United States...as. Neither Presidential nominee Sen. John McCain ...tioned AIDS in their remarks,to Convention delegat...
Breaking Medicine News(10 mins):Health News:Big Tobacco's Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses 2Health News:Big Tobacco's Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses 3Health News:Big Tobacco's Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses 4Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Nearly Half of Americans Won't Flee Without Fido 2Health News:Nearly Half of Americans Won't Flee Without Fido 3Health News:Nearly Half of Americans Won't Flee Without Fido 4Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...lished a definite link between risk of pelvic frac...o the study, women who receive radiotherapy for ce...isk// for fracture of the pelvis. This study highl...f cancer treatment in the elderly. Falls are the ...
...e over the safety of artificial sweeteners got an ...trol Council today stated that a rat study conduct...tradictory with the extensive scientific research ...The U.S. Food & Drug Administration (FDA) has said...
...tive groups in the United States, who had voiced v...ailability of the "morning-after" pill, are now ha...ical cancer vaccines.// These vaccines manufacture... still in the experimental stage and are years awa...
...e potential to be the healthcare crisis manager fo...ical tourism, experts say.// Speaking at a health ...dustry (CII) and the Indian Health Care Foundation...uld double the expenditure on healthcare and facil...
Other Medicine News:Health News:Radiation Risk of Pelvic Fracture in Elderly Women 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 3Health News:Religious groups overcome objections to cervical cancer vaccines 2Health News:India Can Manage World’s Healthcare Crisis By 202 2
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: